After-Hours Movers

Onconova Therapeutic (NASDAQ: ONTX) 13.4% HIGHER; Steven Cohen's fund Point72 Asset Management, L.P. disclosed a 9.99%, or 3,230,434 share, stake in the company.

Aravive, Inc. (Nasdaq: ARAV) 13.3% LOWER; announced that it has commenced an underwritten public offering of the sale of its shares of common stock.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.3% HIGHER; received the official minutes from the Breakthrough Therapy Type B Clinical Guidance meeting with the U.S. Food and Drug Administration (FDA) for Tonmya®* (or TNX-102 SL, cyclobenzaprine sublingual tablets) for the treatment of posttraumatic stress disorder (PTSD). The minutes are consistent with the the guidance received at the meeting. As previously announced, the primary endpoint of the RECOVERY Phase 3 trial will be at Week 12, and the Company plans to add an unblinded interim analysis that allows for a potential sample size adjustment. The ongoing RECOVERY trial is enrolling patients with PTSD from civilian or military traumas that occurred within nine years of screening.

Athersys, Inc. (Nasdaq: ATHX) 12% LOWER; negative mention by STAT's Feuerstein

Guess? (NYSE: GES) 4.6% LOWER; reported Q3 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $616 million versus the consensus estimate of $620.32 million. Guess? sees Q4 2020 EPS of $1.07-$1.12, versus the consensus of $1.09.

Dell Technologies (NYSE: DELL) 4.1% LOWER; reported Q3 EPS of $1.75, $0.13 better than the analyst estimate of $1.62. Revenue for the quarter came in at $22.84 billion versus the consensus estimate of $23.04 billion. lowers FY20 revenue guidance to $91.8-$92.5 billion, versus the consensus of $93.54 billion.

Box (NYSE: BOX) 3.9% HIGHER; reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $177.2 million versus the consensus estimate of $174.63 million. Box sees Q4 2020 EPS of $0.04-$0.05, versus the consensus of $0.04. Box sees Q4 2020 revenue of $181-182 million, versus the consensus of $180.76 million. Box sees FY2020 EPS of $0.01, versus the consensus of $0.01. Box sees FY2020 revenue of $693.7-694.7 million, versus the consensus of $690.9 million.

VMware (NYSE: VMW) 1.9% HIGHER; reported Q3 EPS of $1.49, $0.06 better than the analyst estimate of $1.43. Revenue for the quarter came in at $2.46 billion versus the consensus estimate of $2.41 billion.

HP, Inc. (NYSE: HPQ) 1.3% HIGHER; reported Q4 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.27 billion. HP, Inc. sees Q1 2020 EPS of $0.53-$0.56, versus the consensus of $0.54. HP, Inc. sees FY2020 EPS of $2.24-$2.32, versus the consensus of $2.23.

Autodesk (NASDAQ: ADSK) 0.8% LOWER; reported Q3 EPS of $0.78, $0.06 better than the analyst estimate of $0.72. Revenue for the quarter came in at $843 million versus the consensus estimate of $825.77 million. Autodesk sees Q4 2020 EPS of $0.86-$0.91, versus the consensus of $0.93. Autodesk sees Q4 2020 revenue of $880-895 billion, versus the consensus of $897.9 billion.

Veeva Systems (NYSE: VEEV) 0.8% HIGHER; reported Q3 EPS of $0.60, $0.06 better than the analyst estimate of $0.54. Revenue for the quarter came in at $280.9 million versus the consensus estimate of $274.78 million. Veeva Systems sees Q4 2020 EPS of $0.51-$0.52, versus the consensus of $0.52. Veeva Systems sees Q4 2020 revenue of $296-299 million, versus the consensus of $279.9 million.